Enterprise Trust & Investment’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$1.54M Sell
14,650
-450
-3% -$53.4K 0.64% 46
2022
Q1
$1.93M Sell
15,100
-1,844
-11% -$222K 0.69% 39
2021
Q4
$2.09M Buy
16,944
+7,210
+74% +$944K 0.73% 37
2021
Q3
$1.38M Hold
9,734
0.56% 50
2021
Q2
$1.52M Sell
9,734
-51
-0.5% -$8.26K 0.62% 45
2021
Q1
$1.52M Hold
9,785
0.68% 42
2020
Q4
$1.52M Hold
9,785
0.72% 40
2020
Q3
$1.29M Hold
9,785
0.72% 35
2020
Q2
$1.13M Hold
9,785
0.68% 41
2020
Q1
$960K Hold
9,785
0.67% 40
2019
Q4
$1.42M Sell
9,785
-1,030
-10% -$142K 0.79% 38
2019
Q3
$1.44M Sell
10,815
-1,030
-9% -$133K 0.88% 39
2019
Q2
$1.35M Buy
+11,845
New +$1.39M 0.84% 40

Other funds holding ZBH

Enterprise Trust & Investment's ZBH Position: Q2 2022 in Review

Enterprise Trust & Investment reduced its Zimmer Biomet (ZBH) stake by 3% in Q2 2022, selling an estimated $53.4K and leaving 14,650 shares worth $1.54M. The position accounts for 0.64% of the portfolio, ranked #46.

Enterprise Trust & Investment first reported a position in ZBH in Q2 2019 and has held it in 13 quarters since. The position peaked at $2.09M in Q4 2021. 956 funds tracked by Wall St. Rank hold ZBH as of Q2 2022.

  • Enterprise Trust & Investment held 14,650 shares of Zimmer Biomet worth $1.54M as of Q2 2022.
  • Enterprise Trust & Investment sold 450 Zimmer Biomet shares in Q2 2022, an estimated $53.4K.
  • Zimmer Biomet made up 0.64% of Enterprise Trust & Investment's portfolio in Q2 2022, its #46 holding.
  • Enterprise Trust & Investment first reported a position in Zimmer Biomet in Q2 2019 and has held it in 13 quarters since.
  • Enterprise Trust & Investment's Zimmer Biomet position peaked at $2.09M in Q4 2021.
  • 956 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2022.

Based on Enterprise Trust & Investment's 13F filing for Q2 2022, filed 22 Jul 2022.